A new National Cancer Plan, announced by Health Secretary and cancer survivor, aims to raise England’s cancer survival rates and save an estimated 320,000 lives by 2035.

The plan positions cancer care as part of NHS modernization, targeting reduced delays and the use of medical advances to improve life chances for patients.

A £2 billion package underpins the strategy to transform services and lift the five-year survival rate toward 75% by 2035, up from roughly 60% today.

A key challenge cited is the need to improve coordination and timely sharing of imaging and pathology results, with critics urging that this be addressed alongside large-scale AI initiatives to hit 2029 targets.

The plan foresees a dramatic rise in robot-assisted procedures, from about 70,000 to 500,000 a year by 2035, with benefits including smaller incisions and shorter hospital stays.

Experts such as Professor Peter Johnson, Sarah Scobie, and Michelle Mitchell comment on the plan’s ambitions and the reforms needed to realise its impact.

Context highlights rising cancer incidence and concerns that many NHS trusts are missing targets, underscoring the urgency of reform.

£2.3 billion is earmarked to deliver 9.5 million extra cancer tests by 2029, funding more scanners, automated testing, and longer hours at community diagnostic centres.

An additional £2.3 billion will fund genomic testing for all patients who may benefit, guiding more personalized treatment decisions.

The plan targets meeting all waiting-time standards by 2029, including 85% of patients starting treatment within 62 days of referral, with current performance around 70% in November.

Reactions were mixed: Cancer Research UK welcomed the ambition but urged timely treatment, while health thinktanks warned that basic cancer care must improve alongside new technologies.

Overall aims include earlier diagnosis, faster treatment, expanded testing capacity, and greater use of technology with more scanners, digital tools, automated testing, extended-hours community centres, and expanded robot-assisted surgery.